Results 141 to 150 of about 1,662 (181)

Aqueous Humor Concentration of Bevacizumab After Subconjunctival Injection in Rabbit

open access: yesJournal of Ocular Pharmacology and Therapeutics, 2010
To investigate whether bevacizumab may be delivered into the anterior chamber after subconjunctival administration and its pharmacokinetics in aqueous humor.The right eye of 33 rabbits received subconjunctival injection of 2.5 mg of subconjunctival bevacizumab. Three rabbits were sacrificed at each of the following time points: 0.5, 1, 2, 4, 8, 12, 24,
Moon Jung, Kim   +3 more
openaire   +3 more sources

Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Recurrent Pterygium

Current Eye Research, 2008
We report on the use of subconjunctival bevacizumab on corneal vessel density in recurrent pterygia.The charts of 5 patients with recurrent pterygium, who received subconjunctival injections of bevacizumab (2.5 mg/0.1 ml) were retrospectively reviewed. Ophthalmic evaluation included Snellen visual acuity (VA), tonometry and complete examination before ...
Irit Bahar, Igor Kaiserman
exaly   +3 more sources

Subconjunctival Bevacizumab Injection for Corneal Neovascularization

Cornea, 2008
To report on the clinical use of subconjunctival bevacizumab in patients with corneal neovascularization.The charts of 10 consecutive patients with corneal neovascularization who received subconjunctival injections of bevacizumab (2.5 mg/0.1 mL) were reviewed.
Irit Bahar, Igor Kaiserman
exaly   +3 more sources

The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization

International Ophthalmology, 2013
To evaluate the effects of various doses of subconjunctival bevacizumab injections in the treatment of patients with corneal neovascularization. During the 6-month-follow-up, no significant ocular or systemic adverse events were observed related to the subconjunctival bevacizumab injection.
Suphi Acar
exaly   +3 more sources

Subconjunctival Injection of Bevacizumab in the Treatment of Corneal Neovascularization Associated With Lipid Deposition

open access: yesCornea, 2011
To determine the effects on corneal neovascularization (NV) and lipid deposition after subconjunctival injection of bevacizumab in patients who had NV associated with lipid keratopathy.A case interventional study enrolled 18 patients (18 eyes) with lipid keratopathy.
Hsiao-Sang, Chu   +6 more
openaire   +3 more sources

Subconjunctival and Intracorneal Bevacizumab Injection for Corneal Neovascularization in Lipid Keratopathy

open access: yesCornea, 2009
The purpose of this study was to evaluate the efficacy and safety of subconjunctival and corneal intrastromal bevacizumab injections on corneal neovascularization in patients with lipid keratopathy.Three eyes of 3 patients with lipid keratopathy accompanied by corneal neovascularization received at least 2 subconjunctival and corneal intrastromal ...
Joo Youn, Oh   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy